Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Timolol Maleate Gel in Superficial Proliferating Infantile Hemangioma
CTR20262646Phase 3Active
- Sponsor
- Ark Biosciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of timolol in Capillary Haemangioma, sponsored by Ark Biosciences. Started Jul 2026; status: active.
02
Drugs
timolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on CTR20262646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262646.